Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kejal Kantarci

Showing results (1-10 of 389) with videos related to

Pageof 39
Sort By:
Cell|August 4, 2023
Toward imaging of alpha-synuclein with PETKejal Kantarci
Neuroimaging Clinics of North America|August 10, 2013
Magnetic resonance spectroscopy in common dementiasKejal Kantarci
The Lancet. Neurology|December 23, 2021
2021 marks a new era for Alzheimer's therapeuticsKejal Kantarci
Journal of Magnetic Resonance Imaging : JMRI|March 26, 2013
Proton MRS in mild cognitive impairmentKejal Kantarci
Frontiers in Aging Neuroscience|November 29, 2014
Fractional anisotropy of the fornix and hippocampal atrophy in Alzheimer's diseaseKejal Kantarci
Expert Review of Neurotherapeutics|September 16, 2005
Magnetic resonance markers for early diagnosis and progression of Alzheimer's diseaseKejal Kantarci
Frontiers in Neurology|March 19, 2020
Imaging Biomarkers for Neurodegeneration in Presymptomatic Familial Frontotemporal Lobar DegenerationQin Chen, Kejal Kantarci
Neurology|November 2, 2012
Imaging markers offer promise: dream enactment may predict your patient's futureSuzanne Stevens, Kejal Kantarci
International Psychogeriatrics|February 5, 2021
Decreased glutamine and glutamate: an early biomarker of neurodegenerationBurcu Zeydan, Kejal Kantarci
International Journal of Molecular Sciences|September 28, 2024
Understanding Proton Magnetic Resonance Spectroscopy Neurochemical Changes Using Alzheimer's Disease Biofluid, PET, Postmortem Pathology Biomarkers, and APOE GenotypeFirat Kara, Kejal Kantarci
Pageof 39

Showing results (1-10 of 389) with videos related to

Sort By:
Pageof 39
Cell|August 4, 2023
Toward imaging of alpha-synuclein with PETKejal Kantarci
Neuroimaging Clinics of North America|August 10, 2013
Magnetic resonance spectroscopy in common dementiasKejal Kantarci
The Lancet. Neurology|December 23, 2021
2021 marks a new era for Alzheimer's therapeuticsKejal Kantarci
Journal of Magnetic Resonance Imaging : JMRI|March 26, 2013
Proton MRS in mild cognitive impairmentKejal Kantarci
Frontiers in Aging Neuroscience|November 29, 2014
Fractional anisotropy of the fornix and hippocampal atrophy in Alzheimer's diseaseKejal Kantarci
Expert Review of Neurotherapeutics|September 16, 2005
Magnetic resonance markers for early diagnosis and progression of Alzheimer's diseaseKejal Kantarci
Frontiers in Neurology|March 19, 2020
Imaging Biomarkers for Neurodegeneration in Presymptomatic Familial Frontotemporal Lobar DegenerationQin Chen, Kejal Kantarci
Neurology|November 2, 2012
Imaging markers offer promise: dream enactment may predict your patient's futureSuzanne Stevens, Kejal Kantarci
International Psychogeriatrics|February 5, 2021
Decreased glutamine and glutamate: an early biomarker of neurodegenerationBurcu Zeydan, Kejal Kantarci
International Journal of Molecular Sciences|September 28, 2024
Understanding Proton Magnetic Resonance Spectroscopy Neurochemical Changes Using Alzheimer's Disease Biofluid, PET, Postmortem Pathology Biomarkers, and APOE GenotypeFirat Kara, Kejal Kantarci
Pageof 39